Mr. Bartch is an experienced entrepreneur. He co-founded AudioTranscriptionist.com and founded the Denver-based dispensary, Doctor’s Orders, in 2009. He later founded a boutique investment firm that operated throughout the U.S. and Canadian markets. In 2014, Mr. Bartch co-founded Cannabase.io, the most significant and sophisticated legal cannabis wholesale platform in the United States. He took successful exits from AudioTranscriptionist.com, Doctor’s Orders and Cannabase.io.
Mr. Michaels previously consulted for various hemp businesses through his company, Emerald Baron. Before that, he served as general manager for ebbu, a top multi-platform cannabinoid research and technology firm. By 2018, ebbu was the cutting-edge leader in cannabinoid science and was acquired for CAD$429 million by Canopy Growth Corporation, the largest cannabis company in the world. Mr. Michaels has held executive roles with multiple large brands throughout the cannabis vertical. He also served on the business development team for a Google Ventures company, developed a national snowboard brand and was one of four entrepreneurs who created Colorado’s first-ever glass recycling company.
As an experienced geneticist, Mr. Roscow has spent his academic and professional career identifying valuable and unique medicinal molecules found in nature. He holds both master’s and bachelor’s degrees in biology. Prior to joining Mydecine, Mr. Roscow was director of genetics at Victory Hemp Foods and also at ebbu, which was acquired as a subsidiary of Canopy Growth Corporation, the largest cannabis company in the world. At ebbu, Mr. Roscow ran the world’s first cannabis genetic editing laboratory. He has leveraged an expertise in genomics, evolution and molecular biology to identify novel molecules and advance their use in a pharmacological context. His work has resulted in multiple patent filings and accolades in a variety of scientific and popular publications.
Mr. Ditto is a seasoned executive with experience helping small and mid-market companies develop and execute strategic plans, while ensuring the accounting, finance and administrative capabilities scale appropriately to support growth objectives. He has served in leadership roles for 20+ years in multiple industries, including health sciences, heading initiatives to build finance function capabilities, improve profits and secure capital. He brings experience in SEC reporting, business analytics and systems, cash management, internal controls, risk management and building compliance functions for regulated companies. Mr. Ditto recently led a financial services business turnaround, improving profits by $15 million annually, as well as collaborating with operations to restructure a medical device business unit, increasing profits by $10 million annually.
Dr. Jetly is the former chief of psychiatry for the Canadian Armed Forces and retired in 2021 as a colonel after 31 years of service. He began his career as a general duty medical officer and flight surgeon deploying on missions in Rwanda and the Middle East. He spent his final 20 years as a psychiatrist deploying twice and leading mental health programs in Afghanistan. Dr. Jetly maintains academic appointments at Dalhousie University and the University of Ottawa. He is the inaugural chair of the CF Brigadier Jonathan C. Meakins CBE, RCMAC, and chair in Military Mental Health at the Royal Ottawa Hospital. During his career, Dr. Jetly has led initiatives within Canada and NATO to better understand and innovate solutions in the mental health field. He has published extensively on topics such as PTSD, suicide, leveraging technology in mental health and occupational psychiatry.
Mr. Stein is an experienced attorney and business advisor with expertise in all aspects of government-driven legal matters including legislation, regulations, lobbying and litigation. For more than 40 years, he has been counseling private sector clients and managing their relationships with government, and he brings to Mydecine vast business regulatory experience in the United States and internationally. Mr. Stein has been featured in Leading Lawyers, Super Lawyers and Best Lawyers in America, and he holds the coveted AV rating for professionalism and ethics by the Martindale-Hubbell rating service.
Ms. Riggleman has spent the past 10 years in the clinical research industry and has worked closely with cross-functional teams to develop clinical evidence generation strategies for global indication submissions. She has supported and published research in robotics, orthopedics, trauma, biologics, transcranial magnetic stimulation and psychedelic-assisted psychotherapy. Ms. Riggleman received her master of science in health science degree in the field of clinical research administration from The George Washington University.
For the past 10 years, Ms. Kervitsky has enjoyed working with small startups and Fortune 500 companies, where she has developed and implemented strategic B2B marketing and communication initiatives. In these roles, she has gained experience working with subject matter experts and cross-functional teams to achieve business objectives in a variety of industries, including SaaS, biotechnology, and health and wellness. Ms. Kervitsky is currently pursuing a master’s degree in business administration in Denver, CO.